FBP vaccine: Preliminary Phase IIa data

Preliminary data from the Phase IIa portion of an open-label, U.S. Phase I/IIa trial in 51 patients with ovarian or endometrial cancer showed that 6 monthly injections of 100, 500 or 1,000 ug intrader...